On 26 January, a fourth case of the virus, unconnected to previous cases, was detected.
The ultimate goal: supply a safe, effective vaccine in 2021.
Retrieved 9 February 2020.
The MCO was later extended to the 4th phase.
Retrieved 3 May 2020.
Even with MCO 2.